These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 15122757

  • 1. Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice.
    Ip E, Farrell G, Hall P, Robertson G, Leclercq I.
    Hepatology; 2004 May; 39(5):1286-96. PubMed ID: 15122757
    [Abstract] [Full Text] [Related]

  • 2. Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice.
    Ip E, Farrell GC, Robertson G, Hall P, Kirsch R, Leclercq I.
    Hepatology; 2003 Jul; 38(1):123-32. PubMed ID: 12829994
    [Abstract] [Full Text] [Related]

  • 3. Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro.
    Yu J, Zhang S, Chu ES, Go MY, Lau RH, Zhao J, Wu CW, Tong L, Zhao J, Poon TC, Sung JJ.
    Int J Biochem Cell Biol; 2010 Jun; 42(6):948-57. PubMed ID: 20156580
    [Abstract] [Full Text] [Related]

  • 4. Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis.
    Sugino H, Kumagai N, Watanabe S, Toda K, Takeuchi O, Tsunematsu S, Morinaga S, Tsuchimoto K.
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1909-16. PubMed ID: 18422963
    [Abstract] [Full Text] [Related]

  • 5. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
    Larter CZ, Yeh MM, Cheng J, Williams J, Brown S, dela Pena A, Bell-Anderson KS, Farrell GC.
    J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
    [Abstract] [Full Text] [Related]

  • 6. Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet.
    Nagasawa T, Inada Y, Nakano S, Tamura T, Takahashi T, Maruyama K, Yamazaki Y, Kuroda J, Shibata N.
    Eur J Pharmacol; 2006 Apr 24; 536(1-2):182-91. PubMed ID: 16574099
    [Abstract] [Full Text] [Related]

  • 7. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice.
    McCuskey RS, Ito Y, Robertson GR, McCuskey MK, Perry M, Farrell GC.
    Hepatology; 2004 Aug 24; 40(2):386-93. PubMed ID: 15368443
    [Abstract] [Full Text] [Related]

  • 8. Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis.
    Dixon LJ, Berk M, Thapaliya S, Papouchado BG, Feldstein AE.
    Lab Invest; 2012 May 24; 92(5):713-23. PubMed ID: 22411067
    [Abstract] [Full Text] [Related]

  • 9. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ, Yeh MM, Van Rooyen DM, Brooling J, Ghatora K, Farrell GC.
    J Gastroenterol Hepatol; 2012 Feb 24; 27(2):341-50. PubMed ID: 21929649
    [Abstract] [Full Text] [Related]

  • 10. VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice.
    Velayudham A, Dolganiuc A, Ellis M, Petrasek J, Kodys K, Mandrekar P, Szabo G.
    Hepatology; 2009 Mar 24; 49(3):989-97. PubMed ID: 19115316
    [Abstract] [Full Text] [Related]

  • 11. MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes.
    Larter CZ, Yeh MM, Williams J, Bell-Anderson KS, Farrell GC.
    J Hepatol; 2008 Sep 24; 49(3):407-16. PubMed ID: 18534710
    [Abstract] [Full Text] [Related]

  • 12. Adenovirus-mediated peroxisome proliferator activated receptor gamma overexpression prevents nutritional fibrotic steatohepatitis in mice.
    Nan YM, Han F, Kong LB, Zhao SX, Wang RQ, Wu WJ, Yu J.
    Scand J Gastroenterol; 2011 Mar 24; 46(3):358-69. PubMed ID: 20969493
    [Abstract] [Full Text] [Related]

  • 13. Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol mediated liver fibrosis in mice.
    Nan YM, Kong LB, Ren WG, Wang RQ, Du JH, Li WC, Zhao SX, Zhang YG, Wu WJ, Di HL, Li Y, Yu J.
    Lipids Health Dis; 2013 Feb 06; 12():11. PubMed ID: 23388073
    [Abstract] [Full Text] [Related]

  • 14. Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis.
    Galastri S, Zamara E, Milani S, Novo E, Provenzano A, Delogu W, Vizzutti F, Sutti S, Locatelli I, Navari N, Vivoli E, Caligiuri A, Pinzani M, Albano E, Parola M, Marra F.
    Clin Sci (Lond); 2012 Oct 06; 123(7):459-71. PubMed ID: 22545719
    [Abstract] [Full Text] [Related]

  • 15. PPARalpha activation increases triglyceride mass and adipose differentiation-related protein in hepatocytes.
    Edvardsson U, Ljungberg A, Lindén D, William-Olsson L, Peilot-Sjögren H, Ahnmark A, Oscarsson J.
    J Lipid Res; 2006 Feb 06; 47(2):329-40. PubMed ID: 16282640
    [Abstract] [Full Text] [Related]

  • 16. Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis.
    Zhang S, Wang J, Liu Q, Harnish DC.
    J Hepatol; 2009 Aug 06; 51(2):380-8. PubMed ID: 19501927
    [Abstract] [Full Text] [Related]

  • 17. Sesame oil attenuates nutritional fibrosing steatohepatitis by modulating matrix metalloproteinases-2, 9 and PPAR-γ.
    Periasamy S, Hsu DZ, Chang PC, Liu MY.
    J Nutr Biochem; 2014 Mar 06; 25(3):337-44. PubMed ID: 24445078
    [Abstract] [Full Text] [Related]

  • 18. Induction of heme oxygenase-1 protects against nutritional fibrosing steatohepatitis in mice.
    Wang RQ, Nan YM, Wu WJ, Kong LB, Han F, Zhao SX, Kong L, Yu J.
    Lipids Health Dis; 2011 Feb 12; 10():31. PubMed ID: 21314960
    [Abstract] [Full Text] [Related]

  • 19. Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice.
    Nan YM, Fu N, Wu WJ, Liang BL, Wang RQ, Zhao SX, Zhao JM, Yu J.
    Scand J Gastroenterol; 2009 Feb 12; 44(3):358-65. PubMed ID: 18991162
    [Abstract] [Full Text] [Related]

  • 20. COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator.
    Yu J, Ip E, Dela Peña A, Hou JY, Sesha J, Pera N, Hall P, Kirsch R, Leclercq I, Farrell GC.
    Hepatology; 2006 Apr 12; 43(4):826-36. PubMed ID: 16557554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.